Durable Polymer Versus Biodegradable Polymer Drug-Eluting Stents in Acute Coronary Syndrome Patients With High Ischemic Risk: Three-Year Post Hoc Analysis of the HOST-REDUCE-POLYTECH-ACS Trial

被引：0
|
作者：
Han, Seokmoon [1 ]
Hwang, Doyeon [1 ]
Kang, Jeehoon [1 ]
Park, Kyung Woo [1 ]
Han, Jung-Kyu [1 ]
Yang, Han-Mo [1 ]
Kang, Hyun-Jae [1 ]
Koo, Bon-Kwon [1 ]
Kim, Hyo-Soo [1 ]
机构：
[1] Seoul Natl Univ Hosp, Seoul, South Korea
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 84卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
TCT-431
引用
收藏
页码：B127 / B128
页数：2
相关论文
共 50 条
  • [41] Meta-analysis of bioabsorbable versus durable polymer drug-eluting stents in 20,005 patients with coronary artery disease: An update
    Lupi, Alessandro
    Secco, Gioel Gabrio
    Rognoni, Andrea
    Lazzero, Maurizio
    Fattori, Rossella
    Sheiban, Imad
    Bongo, Angelo Sante
    Bolognese, Leonardo
    Agostoni, Pierfrancesco
    Porto, Italo
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2014, 83 (06) : E193 - E206
  • [42] Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients: BIOFLOW V Acute Coronary Syndromes Subgroup
    Roguin, Ariel
    Kandzari, David E.
    Marcusohn, Erez
    Koolen, Jacques J.
    Doros, Gheorghe
    Massaro, Joseph M.
    Garcia-Garcia, Hector M.
    Bennett, Johan
    Gharib, Elie G.
    Cutlip, Donald E.
    Waksman, Ron
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2018, 11 (10)
  • [43] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): 3-Year Results of the Acute Coronary Syndrome Subgroup Analysis
    Kandzari, David
    Doros, Gheorghe
    Garcia-Garcia, Hector
    Bennett, Johan
    Gharib, Elie
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 76 (17) : B17 - B18
  • [44] TWO-YEAR SAFETY AND EFFICACY OF DURABLE POLYMER TWO-YEAR SAFETY AND EFFICACY OF DURABLE POLYMER SECOND-GENERATION DRUG-ELUTING STENT VERSUS BIODEGRADABLE POLYMER DRUG-ELUTING STENT IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION: DATA FROM KOREA ACUTE MYOCARDIAL INFARCTION REGISTRY (KAMIR)
    Kim, In-Cheol
    Hur, Seung-Ho
    Cho, Yun-Kyeong
    Yoon, Hyuck-Jun
    Nam, Chang-Wook
    Kim, Kwon-Bae
    Kim, Min-Seok
    Park, Jin-Cheol
    Kim, Young-Jo
    Kim, Chong-Jin
    Cho, Myeong-Chan
    Jeong, Myung-Ho
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A49 - A49
  • [45] Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents versus Thin Durable Polymer Everolimus-Eluting Stents in Patients Undergoing Coronary Revascularization (BIOFLOW V): Acute Coronary Syndrome Subgroup Analysis.
    Roguin, Ariel
    Kandzari, David
    Marcusohn, Erez
    Koolen, Jacques J.
    Doros, Gheorghe
    Massaro, Joseph
    Garcia-Garcia, Hector
    Bennett, Johan
    Gharib, Elie
    Cutlip, Donald
    Waksman, Ron
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B39 - B40
  • [46] Long-term outcomes of biodegradable polymer versus durable polymer drug-eluting stents in patients with diabetes a pooled analysis of individual patient data from 3 randomized trials
    de Waha, Antoinette
    Stefanini, Giulio G.
    King, Lamin A.
    Byrne, Robert A.
    Serruys, Patrick W.
    Kufner, Sebastian
    Meier, Bernhard
    Jueni, Peter
    Kastrati, Adnan
    Windecker, Stephan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (06) : 5162 - 5166
  • [47] Comparison of Durable -Polymer-and Biodegradable-Polymer-Based Newer-Generation Drug-Eluting Stents in Patients with Acute Myocardial Infarction and Prediabetes After Successful Percutaneous Coronary Intervention
    Kim, Yong Hoon
    Her, Ae-Young
    Jeong, Myung Ho
    Kim, Byeong-Keuk
    Hong, Sung-Jin
    Kim, Seunghwan
    Ahn, Chul-Min
    Kim, Jung-Sun
    Ko, Young-Guk
    Choi, Donghoon
    Hong, Myeong-Ki
    Jang, Yangsoo
    INTERNATIONAL HEART JOURNAL, 2020, 61 (04) : 673 - 684
  • [48] Real-World Experience of Biodegradable-Polymer Drug Eluting Stents Versus Second-Generation Durable-Polymer Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Sim, Hui Wen
    Thong, Elizabeth H. E.
    Ser, Joon Sin
    Chen, Jason Zhenfeng
    Chan, Mark
    Lee, Ronald
    Tan, Huay Cheem
    Low, Adrian
    Tay, Edgar
    Loh, Poay Huan
    Chan, Koo Hui
    Loh, Joshua
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (13) : B303 - B303
  • [49] Two-Year Safety and Efficacy of Biodegradable Polymer Drug-Eluting Stent Versus Second-Generation Durable Polymer Drug-Eluting Stent in Patients With Acute Myocardial Infarction: Data from the Korea Acute Myocardial Infarction Registry (KAMIR)
    Hur, Seung-Ho
    Kim, In-Cheol
    Won, Ki-Bum
    Cho, Yun-Kyeong
    Yoon, Hyuck-Jun
    Nam, Chang-Wook
    Kim, Kwon-Bae
    Kim, Min-Seok
    Park, Jincheol
    Rha, Seung-Woon
    Chae, Shung-Chull
    Kim, Young-Jo
    Kim, Chong-Jin
    Cho, Myeong-Chan
    Jeong, Myung-Ho
    Ahn, Young-Keun
    Kim, Hyo-Soo
    Ahn, Tae-Hoon
    Seung, Ki-Bae
    Jang, Yangsoo
    Yoon, Jung-Han
    Seong, In-Whan
    Hong, Taek-Jong
    Bae, Jang-Ho
    Park, Seung-Jung
    CLINICAL CARDIOLOGY, 2016, 39 (05) : 276 - 284
  • [50] Five-year outcome of a randomised trial comparing second-generation drug-eluting stents using either biodegradable polymer or durable polymer: the NOBORI biolimus-eluting versus XIENCE/PROMUS everolimus-eluting stent trial (NEXT)
    Natsuaki, Masahiro
    Kozuma, Ken
    Morimoto, Takeshi
    Kadota, Kazushige
    Muramatsu, Toshiya
    Nakagawa, Yoshihisa
    Akasaka, Takashi
    Hanaoka, Keiichi Igarashi
    Tanabe, Kengo
    Morino, Yoshihiro
    Nishikawa, Hideo
    Kimura, Takeshi
    EUROINTERVENTION, 2018, 14 (07) : 815 - 818
12345